Authors: Chen T.; Zamora R.; Zuckerbraun B.; Billiar T.R.

Source: Current Molecular Medicine, Volume 3, Number 6, September 2003 , pp. 519-526(8)

Publisher: Bentham Science Publishers

Abstract:

The complex role of nitric oxide (NO) in the liver can be explained by its patterns of regulation and unique biochemical properties. With a broad range of direct and indirect molecular targets, NO acts as an inhibitor or agonist of cell signaling events. In the liver, constitutively generated NO maintains the hepatic microcirculation and endothelial integrity, while inducible NO synthase (iNOS)-governed NO production can be either beneficial or detrimental. For instance, NO potentiates the hepatic oxidative injury in warm ischemia / reperfusion, while iNOS expression protects against hepatic apoptotic cell death seen in models of sepsis and hepatitis. Anti-apoptotic actions are either cyclic nucleotide dependent or independent, including the expression of heat shock proteins, prevention of mitochondrial dysfunction, and inhibition of caspase activity by S-nitrosation. Whether NO protects or injures is probably determined by the type of insult, the abundance of reactive oxygen species (ROS), the source and amount of NO production and the cellular redox status of liver. Through the use of pharmacological NO donors or NOS gene transfer in conjunction with genetically altered knockout animals, the physiological and pathophysiological roles of NO in liver function can be explored in more detail. The purpose of this paper is to review the current understanding of the role of NO in liver injury.

Keywords: nitric oxide; liver injury; no; inducible no synthase

Document Type: Review article

DOI: http://dx.doi.org/10.2174/1566524033479582

Affiliations: 1: Department of Surgery, University of Pittsburgh School of Medicine, A1010 Presbyterian University Hospital, 3550 Terrace Street, Pittsburgh, PA 15261, USA.

Publication date: 2003-09-01

More about this publication?

• Current Molecular Medicine is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews on fundamental molecular mechanisms of disease pathogenesis, the development of molecular-diagnosis and/or novel approaches to rational treatment. The reviews should be of significant interest to basic researchers and clinical investigators in molecular medicine. Periodically the journal will invite guest editors to devote an issue on a basic research area that shows promise to advance our understanding of the molecular mechanism(s) of a disease or has potential for clinical applications.

Related content

• In this: publication
• By this: publisher
• In this Subject: Pathology
• By this author: Chen T. ;  Zamora R. ;  Zuckerbraun B. ;  Billiar T.R.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers